2024 annual financial data
BridgeBio Pharma 2024 Net margin
BridgeBio Pharma 2024 net margin with verified reported values.
Direct answer
Net margin was -241.44%.
Operating income was -592,973,000 USD and net income was -535,762,000 USD.
Operating cash flow was -520,726,000 USD.
Get free BridgeBio Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 221,902,000 USD
- Operating income
- -592,973,000 USD
- Net income
- -535,762,000 USD
- Operating cash flow
- -520,726,000 USD